Neurological

Scientists in Australia have made an exciting breakthrough in Alzheimer’s research, demonstrating what they describe as the first gene-therapy-based approach for treating advanced forms of the disease.

Research into Alzheimer’s diagnostic technologies has highlighted the potential of a new biomarker in the blood, which was shown to distinguish healthy patients from early asymptomatic Alzheimer’s patients with a high degree of accuracy.

A new study investigating brain activity patterns in schizophrenia patients and their siblings is suggesting a specific brain “signature” could detect the condition in subjects before clinical symptoms appear.

An intriguing study has identified a protein produced by the liver after exercise that could protect the brain from cognitive decline. The study points to the possibility of developing a drug to generate this same effect without the need for exercise.

Scientists have demonstrated an exciting proof of concept for treating Parkinson's in mice, whereby inhibiting a single gene is a one-time treatment eradicated the disease entirely, and kept it at bay for the remainder of their lives.

A tiny brain lesion can shift a person's reality in bizarre and tragic ways, and their ability to describe their condition can lead us toward a fuller understanding of how our complex mental processes work. Here's another oddity to put on the pile.

A study has homed in on how aerobic exercise can improve memory in older subjects with cognitive impairment. The findings suggest it's never too late to start exercising as aerobic activity improves blood flow to parts of the brain linked to memory.

New research describes the successful results of animal studies testing a novel experimental peptide designed to inhibit the receptors responsible for chronic neuropathic pain. The research is now moving towards initial human trials.

Researchers have found that by subjecting people with a mild brain injury to a dose of blue light each morning, they could help to reduce some of its typical side effects such as depression and problems with sleep.

Two new studies are offering novel insights into celiac disease. One study is suggesting immune responses to gluten lead to neurological damage, while another offers hope for a cure demonstrating a nanoparticle treatment can induce immune tolerance.

New research has analyzed hundreds of brain scans from patients with schizophrenia revealing two distinct subtypes with differences in gray matter volumes, busting the previously held notion that all schizophrenia patients' brains are the same.

A paper is adding weight to the growing hypothesis suggesting the toxic protein clusters that cause Parkinson’s disease first aggregate in the gut before moving to the brain, and deficiency in a certain enzyme may help this mechanism.